Genomics in the time of COVID-19

From creating COVID-19 test kits to genomic epidemiology, the Philippine Genome Center looks back at past year in its OnePGC virtual conference.

Dr. Marissa Alejandria, the Philippine team leader in the “Solidarity” clinical trial, will talk about “The Treatment Landscape of COVID-19” at noon on Friday, May 8. It is the third episode of the UP webinar series, “Stop COVID Deaths: Clinical Management Updates.”

The 21st anniversary conference of the National Institutes of Health (NIH)-University of the Philippines Manila (UP Manila), held in partnership with the UP Manila Technology Transfer and Business Development Office (TTBDO), focused on the objective of turning health research into innovative products, policies and solutions for the benefit of society. It was held on February 28 at the Bayanihan Center, UNILAB Inc. complex, Pasig City.

International Journal of Infectious Diseases, 61 (2017) 44-50. doi:10.1016/j.ijid.2017.05.017

Reports indicate that HIV (human immunodeficiency virus) infections in the Philippines have reached epidemic proportions. Dr. Salvaña said the NIH provides important scientific evidence for policy and helps us understand, “and potentially defeat the HIV epidemic.” He added that “NIH is currently doing research on the molecular epidemiology and emergence of drug-resistant HIV. We have collaborated with the Department of Health (DOH) in determining rates of drug resistance to antiretrovirals.”

The National Institutes of Health (NIH) – University of the Philippines Manila, in celebration of its 20th anniversary, organized a scientific conference focusing on the importance of work, health, and well-being of the Filipino people. Attended by about 400 participants from colleges and universities, government and non-government organizations, and corporations, the conference was held on March 14 at the Bayanihan Center, UNILAB, Pasig City.